These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10764951)

  • 41. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
    Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
    J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action.
    Mandrika I; Muceniece R; Wikberg JE
    Biochem Pharmacol; 2001 Mar; 61(5):613-21. PubMed ID: 11239505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist.
    Sebhat IK; Martin WJ; Ye Z; Barakat K; Mosley RT; Johnston DB; Bakshi R; Palucki B; Weinberg DH; MacNeil T; Kalyani RN; Tang R; Stearns RA; Miller RR; Tamvakopoulos C; Strack AM; McGowan E; Cashen DE; Drisko JE; Hom GJ; Howard AD; MacIntyre DE; van der Ploeg LH; Patchett AA; Nargund RP
    J Med Chem; 2002 Oct; 45(21):4589-93. PubMed ID: 12361385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes.
    Schiöth HB; Muceniece R; Larsson M; Mutulis F; Szardenings M; Prusis P; Lindeberg G; Wikberg JE
    Eur J Pharmacol; 1997 Jan; 319(2-3):369-73. PubMed ID: 9042613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.
    Cheung AW; Danho W; Swistok J; Qi L; Kurylko G; Rowan K; Yeon M; Franco L; Chu XJ; Chen L; Yagaloff K
    Bioorg Med Chem Lett; 2003 Jan; 13(1):133-7. PubMed ID: 12467633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of feather colour with constitutively active melanocortin 1 receptors in chicken.
    Ling MK; Lagerström MC; Fredriksson R; Okimoto R; Mundy NI; Takeuchi S; Schiöth HB
    Eur J Biochem; 2003 Apr; 270(7):1441-9. PubMed ID: 12653999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity.
    Nickolls SA; Cismowski MI; Wang X; Wolff M; Conlon PJ; Maki RA
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1217-27. PubMed ID: 12604699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Veiksina S; Uhlén S; Petrovska R; Mutule I; Mutulis F; Yahorava S; Prusis P; Wikberg JE
    Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection.
    Lindqvist N; Näpänkangas U; Lindblom J; Hallböök F
    Eur J Pharmacol; 2003 Dec; 482(1-3):85-94. PubMed ID: 14660008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene.
    Desarnaud F; Labbe O; Eggerickx D; Vassart G; Parmentier M
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):367-73. PubMed ID: 8172596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One melanocortin 4 and two melanocortin 5 receptors from zebrafish show remarkable conservation in structure and pharmacology.
    Ringholm A; Fredriksson R; Poliakova N; Yan YL; Postlethwait JH; Larhammar D; Schiöth HB
    J Neurochem; 2002 Jul; 82(1):6-18. PubMed ID: 12091460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors.
    Peng PJ; Sahm UG; Doherty RV; Kinsman RG; Moss SH; Pouton CW
    Peptides; 1997; 18(7):1001-8. PubMed ID: 9357058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
    Ying Y; Lan XP; Tian YP
    Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.